Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 65 (RPL7AP65)

Target
RPL7AP65
Molecular classification
Other (Pseudogene), Ribosomal protein pseudogene
01

Overview

RPL7AP65 is a processed pseudogene of the ribosomal protein L7a gene, present in the human genome but does not encode a functional protein[4][11]. It shares sequence similarity with the protein-coding gene RPL7A, which encodes a structural component of the 60S ribosomal subunit, involved in protein synthesis[1][3]. As a pseudogene, RPL7AP65 does not participate in ribosome function, has no known biological activity, and is not involved in any diseases or drug interactions. The nomenclature reflects its origin as the 65th identified pseudogene of RPL7A in human genomic analysis[9][11].

Other names
RPL7A_30_1522RPL7AP65Ribosomal protein L7a pseudogene 65
02

Mechanism of action

None (not targeted by drugs; no known mechanism of action)

03

Biological functions

None (as a pseudogene, RPL7AP65 is not known to encode a functional protein and does not participate directly in cellular processes)
04

Disease associations

None (no established disease roles; active RPL7A protein is associated with certain diseases, but not the pseudogene RPL7AP65)
05

Safety considerations

None (no clinical or therapeutic relevance)
06

Interacting drugs

None (no drugs interact with this pseudogene)
07

Biomarkers

None (RPL7AP65 is not used as a biomarker)

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 65 (RPL7AP65).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 65 (RPL7AP65).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call